Brisk walking protects against type 2 diabetes – study

Brisk walking protects against type 2 diabetes – study

Kyiv  •  UNN

 • 30844 views

A study published in the British Journal of Sports Medicine found that brisk walking, especially at speeds of more than 6 km/h, reduces the risk of developing Type 2 diabetes by 39%.

Brisk walking significantly reduces the risk of developing diabetes like. The results of this study and meta-analysis were published in the publication British Journal of Sports Medicine, reports UNN.

Details

The study notes that type 2 diabetes is one of the main diseases in the world. According to the World Organization of health, the incidence of diabetes has increased dramatically over the past 30 years.

Currently, more than 537 million people already have such a diagnosis, and as experts estimate that millions of other people are living with this disease, not even suspecting it.

In this case, type 2 diabetes is the main cause of blindness, kidney failure, heart attacks, strokes, and even lower amputations of limbs.

In this regard, the researchers decided to find out how it affects walking is at risk of developing Type 2 diabetes. It turned out that people, those who walk faster than 3 km / h are less likely to develop diabetes than those who prefer to walk slowly.

But what is most interesting is if the walking speed is increased to 6 km / h and above, the risk of this disease is reduced by 39%.

Аdditions

Scientists from Imperial College worked on this study in London, the University of Medical Sciences of Iran and the Norwegian new University College Oslo. The team studied the results of 10 previous ones studies conducted from 1999 to 2022.

A total of 508,121 adults participated in the study from the UK, Japan and the USA.

After the results, scientists encouraged people to walk as often as possible, longer and faster, because now they have another proof of that, that walking is extremely beneficial for a person's overall health.

read also: breakthrough stem cell therapy demonstrates potential in the treatment of multiple sclerosis